Skip to main content
Premium Trial:

Request an Annual Quote

Wamberg Genomic Advisers: Robert Green

Wamberg Genomic Advisers has appointed Robert Green to its advisory board. A medical geneticist and physician-scientist, Green directs the G2P Research Program in the Division of Genetics at Brigham and Women's Hospital and Harvard Medical School. He is principal investigator of the MedSeq project, an NIH-funded randomized trial to explore the use of whole-genome sequencing in the clinical practice of medicine, and co-leads the BabySeq project, evaluating sequencing in newborns.

Green also directs the recently established Brigham Preventive Genomics Clinic, which offers comprehensive genome sequencing and interpretation to healthy adults and their children. He was the lead author of the published recommendations from the American College of Medical Genetics and Genomics for management of incidental findings in clinical sequencing. As an advisor to Wamberg, Green will help guide the firm in its further development of product offerings and programs as well as lead the selection of future advisory board members from the scientific community. 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.